Last Updated on June 22, 2023

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Informa Healthcare

Abbreviation: Amyotroph. Lateral Scler. Front. Degener.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.81

SJR

 1.116

h-Index

 83

Rank

 3507

Important Details

Title Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Standard Abbreviation Amyotroph. Lateral Scler. Front. Degener.
Type of Publication Journal
Discipline Medicine (miscellaneous) (Q1); Neurology (Q1); Neurology (clinical) (Q1)
Impact Score 2.81
SCImago Journal Rank (SJR) 1.116
h-index 83
Overall Rank 3507
Publisher Name Informa Healthcare
Publication Country United Kingdom
International Standard Serial Number (ISSN) 21679223, 21678421
Coverage and History 2013-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
878

About Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration


Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is a journal published by Informa Healthcare. This journal covers the area[s] related to Medicine (miscellaneous), Neurology, Neurology (clinical), etc. The coverage history of this journal is as follows: 2013-2022. The rank of this journal is 3507. This journal's impact score, h-index, and SJR are 2.81, 83, and 1.116, respectively. The ISSN of this journal is/are as follows: 21679223, 21678421.

The best quartile of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is Q1. This journal has received a total of 878 citations during the last three years (Preceding 2022).


Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Impact Score 2022-2023


The latest impact score (IS) of the Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 2.81. It is computed in the year 2023 as per its definition and based on Scopus data. 2.81

It is decreased by a factor of around 0.01, and the percentage change is -0.35% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Impact Score 2023


Impact Score 2022 of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 2.81. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.81
2021 2.82
2020 2.47
2019 2.70
2018 2.52
2017 2.71
2016 2.70
2015 2.86
2014 2.23

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration h-index


  Table Setting

The h-index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 83. By definition of the h-index, this journal has at least 83 published articles with more than 83 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ISSN


The International Standard Serial Number (ISSN) of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is/are as follows: 21679223, 21678421.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Ranking and SCImago Journal Rank (SJR)


The Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is ranked 3507 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.116.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Publisher


Table Setting

The publisher of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is Informa Healthcare. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2013-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is Amyotroph. Lateral Scler. Front. Degener.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Amyotroph. Lateral Scler. Front. Degener.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration


If your area of research or discipline is related to Medicine (miscellaneous), Neurology, Neurology (clinical), etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The latest impact score of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 2.81. It is computed in the year 2023.


What is the h-index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The latest h-index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 83. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The latest SCImago Journal Rank (SJR) of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 1.116. It is calculated in the year 2023.


What is the ranking of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The latest ranking of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 3507. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is published by Informa Healthcare. The publication country of this journal is United Kingdom.


What is the abbreviation of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

This standard abbreviation of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is Amyotroph. Lateral Scler. Front. Degener..


Is "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration" a Journal, Conference or Book Series?

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is a journal published by Informa Healthcare.


What is the scope of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The scope of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is as follows:

  • Medicine (miscellaneous)
  • Neurology
  • Neurology (clinical)

For detailed scope of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, check the official website of this journal.


What is the ISSN of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The International Standard Serial Number (ISSN) of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is/are as follows: 21679223, 21678421.


What is the best quartile for Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The best quartile for Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is Q1.


What is the coverage history of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

The coverage history of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is as follows 2013-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Proceedings of the International Symposium on Power Semiconductor Devices and ICs Conference And Proceedings 7015 49 2.14
Journal of Competition Law and Economics Journal Oxford University Press 14815 29 0.72
Journal of Classical Sociology Journal SAGE Publications Ltd 13766 27 0.83
Modern Language Journal Journal Wiley-Blackwell 918 103 3.89
Sex Education Journal Routledge 5168 41 2.82
Tekstilec Trade Journal Faculty of Natural Sciences and Engineering, Tekstilec 19217 14 0.73
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS Conference And Proceedings Association for Computing Machinery (ACM) 781 100 8.01
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Biological Procedures Online Journal BioMed Central Ltd. 3350 43 6.40
Journal of Immigrant and Refugee Studies Journal Routledge 9246 32 1.46

Check complete list




Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.81
2021 2.82
2020 2.47
2019 2.70
2018 2.52
2017 2.71
2016 2.70
2015 2.86
2014 2.23



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

Annual Review of Vision Science
Annual Reviews Inc. | United States

See All